To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Alternative complement pathway
The alternative pathway of the complement system is a humoral component of the immune system's natural defence against infections which can operate without antibody participation.
The alternative pathway is one of three complement pathways that opsonizes and kills pathogens. The alternative pathway does not require a specific antibody to commence.
Additional recommended knowledge
It is initiated by the spontaneous hydrolysis of C3, which is abundant in the plasma in the blood. "Tickover" occurs through the spontaneous cleavage of the thioester bond in C3 to form C3(H2O).
This change in shape allows the binding of plasma protein Factor B which allows Factor D to cleave Factor B into Ba and Bb.
Bb remains part of the C3(H2O) to form C3(H2O)Bb, this complex is also known as a fluid-phase C3 convertase. This convertase, although only produced in small amounts, can cleave multiple C3 proteins into C3a and C3b.
The alternative pathway C3-convertase consists of the activated B and D factors, forming an unstable compound that can become stable after binding properdin, a serum protein.
After the creation of C3 convertase, the complement system follows the same path regardless of the means of activation (alternative, classical, or MBL). Binding of another C3b-fragment to the C3-convertase of the alternative pathway creates a C5-convertase analoguous to the MBL or classical pathway.
The C5-convertase of the alternative pathway consists of C3bBbC3b also referred to as C3b2Bb (instead of C4b2a3b in the other pathways)
Since C3b is free and abundant in the plasma, it can bind to either a host cell or pathogen surface. To prevent complement activation from proceeding on the host cell, there are several different kinds of regulatory proteins that disrupt the complement activation process:
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Alternative_complement_pathway". A list of authors is available in Wikipedia.|